Basic Information
Experimental Physicochemical Property
| Property Name | Property Value | Unit | Raw Value | Raw Unit | Reference |
|---|---|---|---|---|---|
| Melting Point | 180.0 | ℃ | 178-182 | ℃ | MSDS |
Pharmacokinetic/ Toxicokinetic Property
Not Available
Maximum Dosage
| Property Name | Property Value | Unit | Raw Value | Raw Unit | Annotation | Brand Name | Component | Reference |
|---|---|---|---|---|---|---|---|---|
| Max dose for children | 1.0 | application/day | 1 | application/day | up to 4 days/week | Zithranol-RR | anthralin | PDR |
| Max dose for adolescents | 1.0 | application/day | 1 | application/day | Zithranol-RR | anthralin | PDR | |
| Max dose for adolescents | 1.0 | application/day | 1 | application/day | up to 4 days/week | Zithranol-RR | anthralin | PDR |
| Max dose for adults | 1.0 | appLication/day | 1 | appLication/day | Zithranol-RR | anthralin | PDR | |
| Max dose for adults | 1.0 | appLication/day | 1 | appLication/day | up to 4 days/week | Zithranol-RR | anthralin | PDR |
| Max dose for geriatric | 1.0 | application/day | 1 | application/day | skin/dermal | Zithranol-RR | anthralin | PDR |
| Max dose for geriatric | 1.0 | application/day | 1 | application/day | up to 4 days/week | Zithranol-RR | anthralin | PDR |
Drug Property Radar Chart
Note: Center: Q1-1.5*IQR, Edge: Q3+1.5*IQR; Q1: Quantile 1, Q3: Quantile 3, IQR: Q3-Q1